[go: up one dir, main page]

AU8190987A - Env/gag-polypeptides - Google Patents

Env/gag-polypeptides

Info

Publication number
AU8190987A
AU8190987A AU81909/87A AU8190987A AU8190987A AU 8190987 A AU8190987 A AU 8190987A AU 81909/87 A AU81909/87 A AU 81909/87A AU 8190987 A AU8190987 A AU 8190987A AU 8190987 A AU8190987 A AU 8190987A
Authority
AU
Australia
Prior art keywords
env
gag
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU81909/87A
Other versions
AU604793B2 (en
Inventor
Reiner Gentz
Stuart Le Grice
Jan Mous
Dietrich Stuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU8190987A publication Critical patent/AU8190987A/en
Application granted granted Critical
Publication of AU604793B2 publication Critical patent/AU604793B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU81909/87A 1986-12-05 1987-11-30 Env/gag-polypeptides Ceased AU604793B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8629116 1986-12-05
GB868629116A GB8629116D0 (en) 1986-12-05 1986-12-05 Env/gag polypeptides

Publications (2)

Publication Number Publication Date
AU8190987A true AU8190987A (en) 1988-06-16
AU604793B2 AU604793B2 (en) 1991-01-03

Family

ID=10608515

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81909/87A Ceased AU604793B2 (en) 1986-12-05 1987-11-30 Env/gag-polypeptides

Country Status (5)

Country Link
EP (1) EP0270114A3 (en)
JP (1) JPS63156729A (en)
AU (1) AU604793B2 (en)
GB (1) GB8629116D0 (en)
NZ (1) NZ222766A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612315B2 (en) * 1985-12-17 1991-07-11 Akzo N.V. Immunochemical reagent

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0346022B1 (en) * 1988-06-10 1996-02-14 United Biomedical, Inc. Peptide fragments of HIV
JPH0748276A (en) * 1992-03-26 1995-02-21 Inmeru:Kk Preventing vaccine for hiv infectious disease and production thereof
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
NO311807B1 (en) 1999-03-04 2002-01-28 Bionor Immuno As HIV peptides, antigens, vaccine preparations, immunoassay test kits and a method for detecting antibodies induced by HIV
AU2013273483A1 (en) 2012-06-06 2014-12-11 Bionor Immuno As Vaccine
CA2951616A1 (en) 2014-07-11 2016-01-14 Bionor Immuno As Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152928A (en) * 1982-03-06 1983-09-10 Hiroshi Teramachi Four-way loaded linear bearing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612315B2 (en) * 1985-12-17 1991-07-11 Akzo N.V. Immunochemical reagent

Also Published As

Publication number Publication date
EP0270114A2 (en) 1988-06-08
JPS63156729A (en) 1988-06-29
EP0270114A3 (en) 1990-01-17
NZ222766A (en) 1990-09-26
AU604793B2 (en) 1991-01-03
GB8629116D0 (en) 1987-01-14

Similar Documents

Publication Publication Date Title
AU591007B2 (en) 3-aryloxy-3-substituted propanamines
AU7310987A (en) 1-aralkyl-4-cyano-pyrazoles
AU7931887A (en) Imidazo-benzoxazinones
AU593093B2 (en) Radio-direction-finding
AU6628986A (en) Tots-in-tandem
AU7024087A (en) Groundsheet
AU7553887A (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes
AU6925587A (en) Naphthothiazepinones
AU8063287A (en) Triazolo-pyrimidine-2-sulphonamides
AU7372487A (en) Fire-lighters
AU7686987A (en) Triazolo-pryimidine-2-sulphonamides
AU5988990A (en) 3-alkoxy-2-aminopropylamides
AU7562487A (en) Dartboards
AU6876687A (en) Theft-deterring label-holders
AU579047B2 (en) Pyridopyrimidinediones
AU626472B2 (en) 1-n-dodecylazacycloheptane-2-thione
AU604793B2 (en) Env/gag-polypeptides
AU7182187A (en) 3-carbamoyl-4-hydroxy-coumarins
AU7432087A (en) Roller-ski
AU6791287A (en) Sky-light
AU7769287A (en) 2-oxo-4-carboxy-pyrimidines
AU7725887A (en) 5-substituted-3-phenyl-3-(1h-imidazoyl-1-ylmethyl)-2-methyl- isoxazolidines
AU6804587A (en) 4-aminomethyl-fluoresceins
AU7594487A (en) Decahydronaphth-2-yl-alkylamines
AU8187487A (en) 1-aryloxy-3-amino-2-propanols